Sanofi

YTD

ALL

Why Robinhood?

You can watch Sanofi and buy or sell other stocks, ETFs, and their options commission-free!

About SNY

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories.

CEO

Belén Garijo López

CEOBelén Garijo López

Employees

76,493

Employees76,493

Headquarters

Paris, Ile-de-France

HeadquartersParis, Ile-de-France

Founded

1973

Founded1973

Employees

76,493

Employees76,493

SNY Key Statistics

Market cap

102.76B

Market cap102.76B

Price-Earnings ratio

22.12

Price-Earnings ratio22.12

Dividend yield

4.09%

Dividend yield4.09%

Average volume

2.32M

Average volume2.32M

High today

$42.95

High today$42.95

Low today

$42.34

Low today$42.34

Open price

$42.75

Open price$42.75

Volume

2.24M

Volume2.24M

52 Week high

$52.68

52 Week high$52.68

52 Week low

$40.89

52 Week low$40.89

SNY News

TipRanks 18h

Sanofi Targets Teen Acne With New mRNA Vaccine Trial, Opening a Fresh Growth Avenue for SNY

Sanofi SA (SNY) announced an update on their ongoing clinical study. Sanofi SA (SNY) is launching a Phase 1/2 trial called “A Phase 1/2, Randomized, Double-bli...

TipRanks 18h

Itepekimab COPD Extension Trial Completion: What It Means for Regeneron and Sanofi

Regeneron Pharmaceuticals (REGN), Sanofi (SNYNF) announced an update on their ongoing clinical study. The extension study “A Double-blinded Extension Study to...

Benzinga 1d

Full Transcript: Sanofi Q2 2026 Earnings Call - Benzinga

...

Analyst ratings

50%

of 8 ratings

Buy

50%

Hold

50%

Sell

More SNY News

TipRanks 2d

Sanofi Strikes Strategic Deal With Cheplapharm to Hand Over 20 Mature Medicines and Three Plants

The latest update is out from Sanofi ( (SNY) ). On September 14, 2026, Sanofi announced a strategic partnership with Germany-based Cheplapharm, a European lead...

TipRanks 3d

Sanofi Targets Senior Respiratory Risk With New Phase 2b RSV+HMPV Vaccine Trial

Sanofi SA (SNY) announced an update on their ongoing clinical study. Sanofi SA (SNY) has launched a Phase 2b study called VCA25397 to test a new vaccine for ad...

TipRanks 3d

Sanofi inaugurates Canadian flu vaccine faclity

Sanofi (SNY) inaugurated the Charles Best Building, a flu vaccine manufacturing facility that will manufacture Sanofi’s Fluzone High-Dose influenza vaccine. Thi...

TipRanks 5d

Sanofi Deepens Cheplapharm Tie-Up in Major Mature Medicines Shift

Sanofi ( (FR:SAN) ) has issued an announcement. Sanofi is reshaping its portfolio through a new strategic partnership with Cheplapharm, transferring 20 mature...

TipRanks 5d

Sanofi, Cheplapharm enter strategic partnership

Sanofi (SNY) and Cheplapharm announced their intention to create a strategic partnership under which Cheplapharm would take over from Sanofi a selection of 20 m...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.